Balchem Corp: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Balchem Corp Unternehmen

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Balchem Corp Informationen



BörsenkürzelBCPC

Name des UnternehmensBalchem Corp

IPO-datumJun 03, 1986

CEOMr. Theodore L. (Ted) Harris

Anzahl der mitarbeiter1361

WertpapierartOrdinary Share

GeschäftsjahresendeJun 03

Addresse- -

Stadt- -

BörseNASDAQ Global Select Consolidated

Land- -

Postleitzahl- -

Telefon- -

Website- -

BörsenkürzelBCPC

IPO-datumJun 03, 1986

CEOMr. Theodore L. (Ted) Harris

Führungskräfte von Balchem Corp



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Theodore L. (Ted) Harris

Chairman of the Board, President, Chief Executive Officer

61.58K

-0.77%

Mr. David B. (Dave) Fischer

Independent Director

7.94K

-5.60%

Ms. Hatsuki Miyata

Executive Vice President, Chief Legal Officer and Secretary

1.55K

-23.80%

Mr. Frederic Boned

Senior Vice President, General Manager - Human Nutrition and Health

410.00

-78.03%

Mr. Matthew D. (Matt) Wineinger

Lead Independent Director

--

Mr. C. Martin Bengtsson

Chief Financial Officer, Executive Vice President

--

Ms. Monica Vicente

Independent Director

--

-100.00%

Mr. Olivier Rigaud

Independent Director

--

-100.00%

Mr. Daniel E. Knutson, CPA

Independent Director

--

Mr. Martin L. Reid

Senior Vice President and Chief Supply Chain Officer

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Theodore L. (Ted) Harris

Chairman of the Board, President, Chief Executive Officer

61.58K

-0.77%

Mr. David B. (Dave) Fischer

Independent Director

7.94K

-5.60%

Ms. Hatsuki Miyata

Executive Vice President, Chief Legal Officer and Secretary

1.55K

-23.80%

Mr. Frederic Boned

Senior Vice President, General Manager - Human Nutrition and Health

410.00

-78.03%

Mr. Matthew D. (Matt) Wineinger

Lead Independent Director

--

Mr. C. Martin Bengtsson

Chief Financial Officer, Executive Vice President

--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Product Sales Revenue

255.04M

99.83%

Royalty

426.00K

0.17%

Nach RegionUSD

Name

Umsatz

Anteil

United States

186.71M

73.08%

Foreign Countries

68.76M

26.92%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Product Sales Revenue

255.04M

99.83%

Royalty

426.00K

0.17%

Aktionärsstatistik

Aktualisiert: Wed, Oct 8

Aktionäre

Aktionärstypen

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

13.70%

The Vanguard Group, Inc.

12.01%

Conestoga Capital Advisors, LLC

3.93%

State Street Investment Management (US)

3.79%

Geode Capital Management, L.L.C.

3.03%

Andere

63.54%

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

13.70%

The Vanguard Group, Inc.

12.01%

Conestoga Capital Advisors, LLC

3.93%

State Street Investment Management (US)

3.79%

Geode Capital Management, L.L.C.

3.03%

Andere

63.54%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

51.25%

Investment Advisor/Hedge Fund

28.47%

Hedge Fund

5.75%

Pension Fund

2.58%

Research Firm

2.03%

Sovereign Wealth Fund

1.59%

Bank and Trust

0.96%

Individual Investor

0.59%

Family Office

0.05%

Andere

6.73%

Institutionelle Beteiligung



Aktualisiert: Wed, Oct 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q3

685

30.01M

92.68%

+129.80K

2025Q2

674

29.83M

91.92%

-576.99K

2025Q1

675

29.77M

91.28%

-552.46K

2024Q4

651

29.73M

91.39%

-1.02M

2024Q3

627

29.81M

91.89%

-780.47K

2024Q2

615

29.69M

91.57%

-1.10M

2024Q1

605

29.82M

92.42%

-671.07K

2023Q4

593

29.66M

91.98%

-739.65K

2023Q3

584

29.65M

91.97%

-680.11K

2023Q2

572

29.77M

92.37%

-504.52K

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

BlackRock Institutional Trust Company, N.A.

4.44M

13.67%

-111.30K

-2.45%

Jun 30, 2025

The Vanguard Group, Inc.

3.89M

11.99%

+47.60K

+1.24%

Jun 30, 2025

Conestoga Capital Advisors, LLC

1.15M

3.54%

-19.03K

-1.63%

Jun 30, 2025

State Street Investment Management (US)

1.23M

3.78%

-1.53K

-0.12%

Jun 30, 2025

Geode Capital Management, L.L.C.

980.97K

3.02%

+14.33K

+1.48%

Jun 30, 2025

Wasatch Global Investors Inc

960.09K

2.96%

-108.92K

-10.19%

Jun 30, 2025

Geneva Capital Management LLC

895.53K

2.76%

+64.72K

+7.79%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

575.40K

1.77%

-18.35K

-3.09%

Jun 30, 2025

Norges Bank Investment Management (NBIM)

469.08K

1.45%

+38.60K

+8.97%

Jun 30, 2025

Fidelity Management & Research Company LLC

463.09K

1.43%

+23.54K

+5.36%

Jun 30, 2025

Verbundene ETFs



Aktualisiert: Sun, Nov 2

Name

Anteil

Invesco S&P SmallCap Materials ETF

6.66%

Invesco S&P SmallCap Quality ETF

1.2%

ProShares Russell 2000 Dividend Growers ETF

0.87%

Invesco S&P SmallCap Low Volatility ETF

0.82%

First Trust Horizon Managed Vol Small/Mid ETF

0.82%

OneAscent Small Cap Core ETF

0.69%

SPDR S&P 600 Small Cap Growth ETF

0.66%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.66%

iShares S&P Small-Cap 600 Growth ETF

0.62%

Pacer US Small Cap Cash Cows Growth Leaders ETF

0.56%

Invesco S&P SmallCap Materials ETF

Anteil6.66%

Invesco S&P SmallCap Quality ETF

Anteil1.2%

ProShares Russell 2000 Dividend Growers ETF

Anteil0.87%

Invesco S&P SmallCap Low Volatility ETF

Anteil0.82%

First Trust Horizon Managed Vol Small/Mid ETF

Anteil0.82%

OneAscent Small Cap Core ETF

Anteil0.69%

SPDR S&P 600 Small Cap Growth ETF

Anteil0.66%

Vanguard S&P Small-Cap 600 Growth Index Fund

Anteil0.66%

iShares S&P Small-Cap 600 Growth ETF

Anteil0.62%

Pacer US Small Cap Cash Cows Growth Leaders ETF

Anteil0.56%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 104.59M USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Dec 10, 2024

BCPC.NB Final Cash Dividend of gross USD 0.87 paid on Jan 17, 2025 going ex on Dec 26, 2024

Dec 26, 2024

Jan 17, 2025

Dec 26, 2024

Dec 05, 2023

BCPC.NB Final Cash Dividend of gross USD 0.79 paid on Jan 19, 2024 going ex on Dec 26, 2023

Dec 27, 2023

Jan 19, 2024

Dec 26, 2023

Dec 06, 2022

BCPC.NB Final Cash Dividend of gross USD 0.71 paid on Jan 20, 2023 going ex on Dec 23, 2022

Dec 27, 2022

Jan 20, 2023

Dec 23, 2022

Dec 16, 2021

BCPC.NB Final Cash Dividend of gross USD 0.64 paid on Jan 21, 2022 going ex on Dec 27, 2021

Dec 28, 2021

Jan 21, 2022

Dec 27, 2021

Dec 17, 2020

BCPC.NB Final Cash Dividend of gross USD 0.58 paid on Jan 22, 2021 going ex on Dec 24, 2020

Dec 28, 2020

Jan 22, 2021

Dec 24, 2020

Aktien-Split



Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten